Coronary Stents Market Share
Coronary Stents Market Research Report By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents), By Material (Metal Stents, Polymer Stents, Coated Stents), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs), By Application (Coronary Artery Disease, Peripheral Artery Disease, Acute Myocardial Infarction) and By Regional (North America, Europe, South A...

Market Summary
As per Market Research Future Analysis, the Coronary Stents Market was valued at 6.62 USD Billion in 2024 and is projected to grow to 9.2 USD Billion by 2035, with a CAGR of 3.04% from 2025 to 2035. The market is driven by the rising prevalence of cardiovascular diseases, technological advancements in stent design, and an aging population. Drug-eluting stents are leading the market due to their effectiveness in reducing restenosis rates, while the demand for minimally invasive procedures is increasing.
Key Market Trends & Highlights
The Global Coronary Stents Market is witnessing significant growth driven by various factors.
- Market Size in 2024: 6.62 USD Billion; expected to reach 9.2 USD Billion by 2035. Drug-Eluting Stents segment valued at 2.88 USD Billion in 2024; projected to grow to 4.0 USD Billion by 2035. North America leads the market with a valuation of 2.45 USD Billion in 2024; expected to increase to 3.15 USD Billion by 2035. Aging population projected to reach 2.1 billion aged 60+ by 2050, correlating with increased cardiovascular issues.
Market Size & Forecast
2023 Market Size | USD 6.43 Billion |
2024 Market Size | USD 6.62 Billion |
2035 Market Size | USD 9.2 Billion |
CAGR (2025-2035) | 3.04% |
Largest Regional Market Share in 2024 | North America. |
Major Players
<p>Key players include MicroPort, Philips, Johnson and Johnson, Terumo, B.Braun, Abbott, Boston Scientific, and Medtronic.</p>
Market Trends
The Coronary Stents Market is experiencing significant trends driven by advancements in technology and a growing emphasis on patient-centered care. One of the key market drivers is the increasing prevalence of cardiovascular diseases globally.
Governments worldwide acknowledge this public health crisis and are investing in healthcare infrastructures, promoting preventive measures, and supporting innovative treatments. This focus on improving healthcare outcomes stimulates demand for high-quality coronary stents, which are crucial in addressing heart-related issues.
There are substantial opportunities to be explored in the emerging markets, where increasing healthcare access is coupled with rising disposable incomes. As awareness regarding heart diseases grows, more patients are seeking treatment options, thus fostering greater acceptance of coronary stents.
Additionally, the shift towards minimally invasive procedures is encouraging manufacturers to innovate and improve stent designs for better patient outcomes. Trends in recent times show an increasing adoption of drug-eluting stents over bare-metal stents due to their lower rates of in-stent restenosis.
Health authorities are also focusing on regulatory approvals for new stent technologies that enhance biocompatibility and reduce complications. Furthermore, the rise of telemedicine and remote patient monitoring is transforming how patient care is delivered, creating additional avenues for stent manufacturers to reach patients effectively.
As the market evolves, the integration of technological advances in stent design is expected to enhance performance and patient satisfaction across various regions.
<p>The ongoing advancements in coronary stent technology, particularly in drug-eluting stents, appear to enhance patient outcomes and reduce the incidence of restenosis, suggesting a promising trajectory for the market.</p>
U.S. Food and Drug Administration (FDA)
Coronary Stents Market Market Drivers
Market Growth Projections
The Global Coronary Stents Market Industry is poised for substantial growth over the next decade. Projections indicate that the market will reach a value of 9.2 USD Billion by 2035, reflecting a steady increase in demand for coronary stents. The anticipated compound annual growth rate (CAGR) of 3.04% from 2025 to 2035 underscores the market's resilience and potential for expansion. This growth is driven by various factors, including technological advancements, increasing prevalence of cardiovascular diseases, and a rising geriatric population. As healthcare systems adapt to these trends, the market is likely to experience sustained growth, catering to the evolving needs of patients.
Rising Healthcare Expenditure
The upward trend in global healthcare expenditure is a vital driver for the Global Coronary Stents Market Industry. As countries allocate more resources to healthcare, the availability of advanced medical technologies, including coronary stents, improves. Increased spending on healthcare infrastructure and services allows for better access to cardiac care, which is essential for managing cardiovascular diseases. This trend is particularly evident in developing regions, where investments in healthcare are expanding rapidly. As a result, the market is poised for growth, with projections indicating a market value of 6.62 USD Billion in 2024, reflecting the increasing prioritization of cardiovascular health.
Increasing Geriatric Population
The global demographic shift towards an aging population is a crucial factor influencing the Global Coronary Stents Market Industry. Older adults are more susceptible to cardiovascular diseases, leading to a higher demand for coronary interventions. As the World Health Organization projects that the number of people aged 60 years and older will reach 2.1 billion by 2050, healthcare providers are increasingly focusing on tailored interventions for this demographic. This trend is likely to drive market growth, as older patients often require multiple stenting procedures, thereby increasing the overall demand for coronary stents in the coming years.
Government Initiatives and Funding
Government initiatives aimed at improving cardiovascular health are significantly impacting the Global Coronary Stents Market Industry. Various health authorities are implementing programs to enhance access to advanced medical technologies, including coronary stents. Increased funding for cardiovascular research and treatment options is expected to bolster market growth. For example, initiatives that promote awareness and screening for heart diseases can lead to earlier interventions, thereby increasing the demand for stenting procedures. This proactive approach by governments worldwide is likely to sustain the market's growth momentum, contributing to a projected CAGR of 3.04% from 2025 to 2035.
Technological Advancements in Stent Design
Innovations in stent technology are transforming the landscape of the Global Coronary Stents Market Industry. The development of drug-eluting stents, bioresorbable stents, and advanced materials has enhanced the efficacy and safety of coronary interventions. These advancements not only reduce the risk of restenosis but also improve patient recovery times. For instance, drug-eluting stents have shown to decrease the need for repeat procedures significantly. As the market evolves, these technological improvements are projected to contribute to a market growth trajectory, with an anticipated value of 9.2 USD Billion by 2035, indicating a robust demand for innovative solutions.
Rising Prevalence of Cardiovascular Diseases
The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Coronary Stents Market Industry. As per health statistics, cardiovascular diseases remain the leading cause of mortality worldwide, accounting for approximately 31% of all deaths. This alarming trend necessitates advanced treatment options, including coronary stenting procedures. With an estimated market value of 6.62 USD Billion in 2024, the demand for coronary stents is expected to rise significantly as healthcare systems prioritize interventions that improve patient outcomes. The focus on preventive care and early intervention strategies further propels the growth of this market.
Market Segment Insights
Coronary Stents Market Type Insights
<p>The Coronary Stents Market is categorized into various Types, primarily comprising Drug-Eluting Stents, Bare-Metal Stents, and Bioabsorbable Stents, each holding a distinct share in the overall market.</p>
<p>In 2024, the Drug-Eluting Stents segment is projected to be valued at 3.6 USD Billion, indicating a dominant position in the market. This sub-segment is significant due to the advanced therapeutic benefits these stents provide, as they are designed to release a drug that inhibits tissue growth, thereby reducing the chances of re-narrowing in coronary arteries.</p>
<p>Following closely is the Bare-Metal Stents segment, valued at 2.14 USD Billion in 2024. This segment is essential for patients who may require a temporary solution without the complications associated with drug coatings, making it a viable option in scenarios where the use of medications is limited.</p>
<p>The evolution of these segments captures a vital aspect of the ongoing efforts in the cardiovascular industry to innovate and push boundaries in treatment methodologies. Such advancements and the strategic focus on improving efficacy will potentially reshape the landscape of treatments, making the insights derived from the Coronary Stents Market data invaluable for stakeholders.</p>
<p>Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review</p>
Coronary Stents Market Material Insights
<p>The Coronary Stents Market, with an expected value of 6.62 billion USD in 2024, is experiencing notable growth driven by the increasing prevalence of cardiovascular diseases and the aging global population. The segmentation of the market by Material reveals distinct categories, including Metal Stents, Polymer Stents, and Coated Stents, each playing a critical role in the overall industry.</p>
<p>Metal Stents, often utilized for their strength and ease of deployment, hold a significant market share and are favored in various situations due to their proven long-term outcomes. Polymer Stents, which feature advanced materials, offer potential benefits in biocompatibility and flexibility, catering to patients with specific needs.</p>
<p>Coated Stents enhance performance by delivering medication to the affected area, thus reducing the risk of restenosis. Overall, the Coronary Stents Market is witnessing advancements in technology and materials, with growing investments in Research and Development that highlight opportunities for enhancing patient outcomes and addressing challenges related to stent failure and complications associated with their use.</p>
Coronary Stents Market End Use Insights
<p>The Coronary Stents Market showcases substantial growth within the End Use segment, primarily driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. By 2024, the market is expected to be valued at 6.62 USD Billion, reflecting a positive shift towards advanced healthcare provisions across the globe.</p>
<p>Hospitals remain a dominant force in the End Use segment, providing comprehensive cardiac care through specialized treatment options. Ambulatory Surgical Centers are gaining traction due to their efficiency and cost-effectiveness, catering to patients in need of outpatient surgeries.</p>
<p>Cardiac Catheterization Labs play a crucial role in the performance and success of stenting procedures, highlighting their significance within the healthcare landscape. The market is expected to reflect evolving trends, including technological advancements in stent design,</p>
Coronary Stents Market Application Insights
<p>The Coronary Stents Market is witnessing significant growth driven by the increasing prevalence of cardiovascular diseases, with a market valuation of 6.62 billion USD expected by 2024. Within the Application segment, conditions such as <a href="https://www.marketresearchfuture.com/reports/coronary-artery-disease-therapeutic-market-42000">Coronary Artery Disease</a>, Peripheral Artery Disease, and Acute Myocardial Infarction play pivotal roles.</p>
<p>Coronary Artery Disease is a leading cause of mortality globally and demands advanced treatment solutions like stenting to restore blood flow, making it a crucial area of focus in this market. Peripheral Artery Disease, often overlooked, can lead to severe complications, thereby creating a substantial opportunity for coronary stents to enhance patient outcomes.</p>
<p>Additionally, Acute Myocardial Infarction represents a dire medical emergency requiring prompt intervention, with stents providing essential support in restoring coronary artery patency. The trends in this market reflect a shift towards angioplasty and stenting techniques driven by technological advancements and improved patient management strategies.</p>
Get more detailed insights about Coronary Stents Market Research Report - Global Forecast till 2035
Regional Insights
The Coronary Stents Market exhibits significant regional diversity, with North America leading the charge. In 2024, North America is expected to dominate with a valuation of 2.75 USD Billion, which is projected to grow to 3.63 USD Billion by 2035, reflecting its majority holding in the market due to advanced healthcare infrastructure and high demand for coronary interventions.
Europe follows closely, with a market value of 1.85 USD Billion in 2024, increasing to 2.47 USD Billion by 2035, driven by an aging population and rising prevalence of cardiovascular diseases. In the Asia Pacific region, the market is valued at 1.5 USD Billion in 2024 and is expected to reach 2.08 USD Billion by 2035.
This growth is fueled by increasing healthcare investments and improving access to medical technologies. South America, with a smaller market size of 0.4 USD Billion in 2024, will grow to 0.54 USD Billion by 2035, signifying a developing region with potential for future growth.
The Middle East and Africa represent the smallest share, with a market value of 0.12 USD Billion in 2024 and projected to increase to 0.18 USD Billion by 2035, challenging growth due to limited healthcare access in some areas. Collectively, these regions create a complex landscape for the Coronary Stents Market, influenced by varying economic, health, and social dynamics.
Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review
Key Players and Competitive Insights
The Coronary Stents Market is characterized by a dynamic competitive landscape marked by innovation, strategic partnerships, and a diverse portfolio of products aimed at addressing the growing incidence of cardiovascular diseases.
As the prevalence of heart-related ailments rises globally, the demand for advanced coronary stents has surged, driving manufacturers to develop innovative and effective solutions. The market is influenced by factors such as technological advancements, regulatory approvals, and the ongoing quest for improved patient outcomes, which compel companies to engage in rigorous research and development.
Players in the market are also focusing on cost-effective solutions to meet the needs of healthcare providers and patients, enhancing competition and encouraging market growth.
Boston Scientific Corporation holds a prominent position in the Coronary Stents Market, leveraging its extensive experience and innovative product offerings. The company's strengths lie in its strong research and development capabilities, which allow for the continual introduction of advanced coronary stents that enhance procedural outcomes and minimize complications.
With a global operational footprint, Boston Scientific Corporation has a widespread market presence, supplying advanced solutions to diverse regions. The company’s commitment to innovation is reflected in its comprehensive product range, which includes both drug-eluting and bare-metal stents, catering to various hospital and outpatient settings.
Their focus on clinical evidence and partnerships with healthcare professionals further solidifies their leadership position in the market, making them a key player in the coronary stenting field.
Stentys is another noteworthy player in the Coronary Stents Market, primarily recognized for its innovative self-expanding stent technology designed to treat patients with acute myocardial infarction and other coronary conditions. The company emphasizes its commitment to providing effective solutions that improve patient outcomes and reduce complications associated with cardiovascular interventions.
Stentys has established a strategic market presence through collaborations and partnerships that enhance its distribution channels. The company's focus on research and development has led to a strong portfolio of products specifically tailored for various coronary conditions, further widening its market reach.
Stentys has also engaged in mergers and acquisitions to bolster its technological capabilities and expand its product offerings, positioning itself as a compelling alternative within the global landscape of coronary stenting solutions. Through these initiatives, Stentys aims to address the evolving challenges of healthcare providers and support the growing demand for innovative cardiovascular interventions.
Key Companies in the Coronary Stents Market market include







Industry Developments
Recent developments in the Coronary Stents Market have shown significant activity and progress, particularly with companies like Boston Scientific Corporation, Abbott Laboratories, and Medtronic PLC. In September 2023, Abbott Laboratories announced the launch of an advanced drug-eluting stent, enhancing treatment efficiency for patients with coronary artery disease.
Furthermore, Medtronic PLC has made strides in expanding its product offerings to reflect the growing demand for innovative stenting solutions. Current affairs indicate a continuous evolution in market dynamics, with an increasing emphasis on collaboration among key players.
Notably, in June 2023, Boston Scientific Corporation completed the acquisition of device maker BVS Medical, enhancing its portfolio in the coronary intervention space. The global market valuation for coronary stents is experiencing substantial growth, projected to surpass USD 6 billion by 2025, driven by rising incidences of cardiovascular diseases.
Additionally, regulatory shifts and increasing investment in Research and Development are optimizing product performance and patient outcomes. Over the last two years, the market has seen a pronounced shift towards minimally invasive heart procedures, and in March 2022, Terumo Corporation launched a cutting-edge hybrid stent technology, representing a leap in coronary intervention techniques.
Future Outlook
Coronary Stents Market Future Outlook
<p>The Global Coronary Stents Market is projected to grow at a 3.04% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.</p>
New opportunities lie in:
- <p>Invest in biodegradable stent technology to capture eco-conscious consumers. Develop advanced drug-eluting stents to enhance patient outcomes and reduce restenosis rates. Expand into emerging markets with tailored pricing strategies for affordability.</p>
<p>By 2035, the Coronary Stents Market is expected to exhibit robust growth, reflecting advancements in technology and increasing demand.</p>
Market Segmentation
Coronary Stents Market Type Outlook
- Drug-Eluting Stents
- Bare-Metal Stents
- Bioabsorbable Stents
Coronary Stents Market End Use Outlook
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Labs
Coronary Stents Market Material Outlook
- Metal Stents
- Polymer Stents
- Coated Stents
Coronary Stents Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Coronary Stents Market Application Outlook
- Coronary Artery Disease
- Peripheral Artery Disease
- Acute Myocardial Infarction
Report Scope
Report Attribute/Metric | Details |
Market Size 2023 | 6.43(USD Billion) |
Market Size 2024 | 6.62(USD Billion) |
Market Size 2035 | 9.2(USD Billion) |
Compound Annual Growth Rate (CAGR) | 3.04% (2025 - 2035) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year | 2024 |
Market Forecast Period | 2025 - 2035 |
Historical Data | 2019 - 2024 |
Market Forecast Units | USD Billion |
Key Companies Profiled | Boston Scientific Corporation, Stentys, Q3 Medical Devices Limited, Bayer AG, Biosensors International Group, Cook Medical, Medtronic PLC, Spectranetics, Cardinal Health, Avinger, Terumo Corporation, Johnson & Johnson, Merit Medical Systems, Abbott Laboratories |
Segments Covered | Type, Material, End Use, Application, Regional |
Key Market Opportunities | Emerging markets expansion, Technological advancements in stent design, Increased aging population, Rising prevalence of cardiovascular diseases, Growth in minimally invasive procedures. |
Key Market Dynamics | rising prevalence of cardiovascular diseases, technological advancements in stent design, increasing preference for minimally invasive procedures, growing geriatric population, expanding healthcare infrastructure in emerging markets |
Countries Covered | North America, Europe, APAC, South America, MEA |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
What was the market size of the Coronary Stents Market in 2024?
The Coronary Stents Market was valued at 6.62 USD Billion in 2024.
What is the projected market size for the Coronary Stents Market by 2035?
By 2035, the Coronary Stents Market is projected to reach a value of 9.2 USD Billion.
What is the expected CAGR for the Coronary Stents Market from 2025 to 2035?
The expected compound annual growth rate for the market from 2025 to 2035 is 3.04%.
Which region holds the largest market share for the Coronary Stents Market in 2024?
North America holds the largest market share, valued at 2.75 USD Billion in 2024.
How is the Asia Pacific region expected to grow in the Coronary Stents Market by 2035?
The Asia Pacific region is expected to grow to 2.08 USD Billion by 2035, up from 1.5 USD Billion in 2024.
What are the market values for Drug-Eluting Stents in 2024 and 2035?
The market value for Drug-Eluting Stents is 3.6 USD Billion in 2024 and is expected to rise to 4.6 USD Billion by 2035.
Which companies are considered major players in the Coronary Stents Market?
Major players include Boston Scientific Corporation, Medtronic PLC, and Abbott Laboratories, among others.
What is the expected market value for Bare-Metal Stents in 2035?
The expected market value for Bare-Metal Stents by 2035 is 2.9 USD Billion.
What challenges could impact the growth of the Coronary Stents Market?
Challenges may include regulatory hurdles and competition among established and emerging players.
What segment of the Coronary Stents Market is anticipated to grow the fastest?
The Bioabsorbable Stents segment is anticipated to show significant growth, expected to reach 1.7 USD Billion by 2035.
-
--- "
-
Table of Contents
-
EXECUTIVE SUMMARY
-
Market Overview
-
Key Findings
-
Market Segmentation
-
Competitive Landscape
-
Challenges and Opportunities
-
Future Outlook
-
MARKET INTRODUCTION
-
Definition
-
Scope of the study
-
Research Objective
-
Assumption
-
Limitations
-
RESEARCH METHODOLOGY
-
Overview
-
Data Mining
-
Secondary Research
-
Primary Research
-
Primary Interviews and Information Gathering Process
-
Breakdown of Primary Respondents
-
Forecasting Model
-
Market Size Estimation
-
Bottom-Up Approach
-
Top-Down Approach
-
Data Triangulation
-
Validation
-
MARKET DYNAMICS
-
Overview
-
Drivers
-
Restraints
-
Opportunities
-
MARKET FACTOR ANALYSIS
-
Value chain Analysis
-
Porter's Five Forces Analysis
-
Bargaining Power of Suppliers
-
Bargaining Power of Buyers
-
Threat of New Entrants
-
Threat of Substitutes
-
Intensity of Rivalry
-
COVID-19 Impact Analysis
-
Market Impact Analysis
-
Regional Impact
-
Opportunity and Threat Analysis
-
Coronary Stents Market, BY Type (USD Billion)
-
Drug-Eluting Stents
-
Bare-Metal Stents
-
Bioabsorbable Stents
-
Coronary Stents Market, BY Material (USD Billion)
-
Metal Stents
-
Polymer Stents
-
Coated Stents
-
Coronary Stents Market, BY End Use (USD Billion)
-
Hospitals
-
Ambulatory Surgical Centers
-
Cardiac Catheterization Labs
-
Coronary Stents Market, BY Application (USD Billion)
-
Coronary Artery Disease
-
Peripheral Artery Disease
-
Acute Myocardial Infarction
-
Coronary Stents Market, BY Regional (USD Billion)
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
UK
-
France
-
Russia
-
Italy
-
Spain
-
Rest of Europe
-
APAC
-
China
-
India
-
Japan
-
South Korea
-
Malaysia
-
Thailand
-
Indonesia
-
Rest of APAC
-
South America
-
Brazil
-
Mexico
-
Argentina
-
Rest of South America
-
MEA
-
GCC Countries
-
South Africa
-
Rest of MEA
-
Competitive Landscape
-
Overview
-
Competitive Analysis
-
Market share Analysis
-
Major Growth Strategy in the Coronary Stents Market
-
Competitive Benchmarking
-
Leading Players in Terms of Number of Developments in the Coronary Stents Market
-
Key developments and growth strategies
-
New Product Launch/Service Deployment
-
Merger & Acquisitions
-
Joint Ventures
-
Major Players Financial Matrix
-
Sales and Operating Income
-
Major Players R&D Expenditure. 2023
-
Company Profiles
-
MicroPort
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Philips
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Johnson and Johnson
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Terumo
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
B.Braun
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Abbott
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
ERBE Elektromedizin
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Meril Life Sciences
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Kimal plc
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Apex Medical Technologies
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Medtronic
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Stentys
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Sahajanand Medical Technologies
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Cardinal Health
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Boston Scientific
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Appendix
-
References
-
Related Reports
Coronary Stents Market Segmentation
Coronary Stents Market By Type (USD Billion, 2019-2035)
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
Coronary Stents Market By Material (USD Billion, 2019-2035)
Metal Stents
Polymer Stents
Coated Stents
Coronary Stents Market By End Use (USD Billion, 2019-2035)
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
Coronary Stents Market By Application (USD Billion, 2019-2035)
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
Coronary Stents Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Coronary Stents Market Regional Outlook (USD Billion, 2019-2035)
North America Outlook (USD Billion, 2019-2035)
North America Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
North America Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
North America Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
North America Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
North America Coronary Stents Market by Regional Type
US
Canada
US Outlook (USD Billion, 2019-2035)
US Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
US Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
US Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
US Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
CANADA Outlook (USD Billion, 2019-2035)
CANADA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
CANADA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
CANADA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
CANADA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
Europe Outlook (USD Billion, 2019-2035)
Europe Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
Europe Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
Europe Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
Europe Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
Europe Coronary Stents Market by Regional Type
Germany
UK
France
Russia
Italy
Spain
Rest of Europe
GERMANY Outlook (USD Billion, 2019-2035)
GERMANY Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
GERMANY Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
GERMANY Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
GERMANY Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
UK Outlook (USD Billion, 2019-2035)
UK Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
UK Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
UK Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
UK Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
FRANCE Outlook (USD Billion, 2019-2035)
FRANCE Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
FRANCE Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
FRANCE Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
FRANCE Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
RUSSIA Outlook (USD Billion, 2019-2035)
RUSSIA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
RUSSIA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
RUSSIA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
RUSSIA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
ITALY Outlook (USD Billion, 2019-2035)
ITALY Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
ITALY Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
ITALY Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
ITALY Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
SPAIN Outlook (USD Billion, 2019-2035)
SPAIN Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
SPAIN Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
SPAIN Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
SPAIN Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
REST OF EUROPE Outlook (USD Billion, 2019-2035)
REST OF EUROPE Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
REST OF EUROPE Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
REST OF EUROPE Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
REST OF EUROPE Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
APAC Outlook (USD Billion, 2019-2035)
APAC Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
APAC Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
APAC Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
APAC Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
APAC Coronary Stents Market by Regional Type
China
India
Japan
South Korea
Malaysia
Thailand
Indonesia
Rest of APAC
CHINA Outlook (USD Billion, 2019-2035)
CHINA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
CHINA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
CHINA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
CHINA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
INDIA Outlook (USD Billion, 2019-2035)
INDIA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
INDIA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
INDIA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
INDIA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
JAPAN Outlook (USD Billion, 2019-2035)
JAPAN Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
JAPAN Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
JAPAN Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
JAPAN Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
SOUTH KOREA Outlook (USD Billion, 2019-2035)
SOUTH KOREA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
SOUTH KOREA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
SOUTH KOREA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
SOUTH KOREA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
MALAYSIA Outlook (USD Billion, 2019-2035)
MALAYSIA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
MALAYSIA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
MALAYSIA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
MALAYSIA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
THAILAND Outlook (USD Billion, 2019-2035)
THAILAND Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
THAILAND Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
THAILAND Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
THAILAND Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
INDONESIA Outlook (USD Billion, 2019-2035)
INDONESIA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
INDONESIA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
INDONESIA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
INDONESIA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
REST OF APAC Outlook (USD Billion, 2019-2035)
REST OF APAC Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
REST OF APAC Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
REST OF APAC Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
REST OF APAC Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
South America Outlook (USD Billion, 2019-2035)
South America Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
South America Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
South America Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
South America Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
South America Coronary Stents Market by Regional Type
Brazil
Mexico
Argentina
Rest of South America
BRAZIL Outlook (USD Billion, 2019-2035)
BRAZIL Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
BRAZIL Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
BRAZIL Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
BRAZIL Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
MEXICO Outlook (USD Billion, 2019-2035)
MEXICO Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
MEXICO Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
MEXICO Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
MEXICO Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
ARGENTINA Outlook (USD Billion, 2019-2035)
ARGENTINA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
ARGENTINA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
ARGENTINA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
ARGENTINA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
REST OF SOUTH AMERICA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
REST OF SOUTH AMERICA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
REST OF SOUTH AMERICA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
REST OF SOUTH AMERICA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
MEA Outlook (USD Billion, 2019-2035)
MEA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
MEA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
MEA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
MEA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
MEA Coronary Stents Market by Regional Type
GCC Countries
South Africa
Rest of MEA
GCC COUNTRIES Outlook (USD Billion, 2019-2035)
GCC COUNTRIES Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
GCC COUNTRIES Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
GCC COUNTRIES Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
GCC COUNTRIES Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
SOUTH AFRICA Outlook (USD Billion, 2019-2035)
SOUTH AFRICA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
SOUTH AFRICA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
SOUTH AFRICA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
SOUTH AFRICA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction
REST OF MEA Outlook (USD Billion, 2019-2035)
REST OF MEA Coronary Stents Market by Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
REST OF MEA Coronary Stents Market by Material Type
Metal Stents
Polymer Stents
Coated Stents
REST OF MEA Coronary Stents Market by End Use Type
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
REST OF MEA Coronary Stents Market by Application Type
Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment